Table 2. Objective tumour response in trial B.

	Gastrazole (n=53)	5-FU (n=42)	P
Complete response	0 (0%)	0 (0%)
Partial response	0 (0%)	2 (5%)
Stable disease	15 (29%)	12 (29%)
Progressive disease	38 (71%)	28 (66%)
Objective response rate (95% confidence interval)	0%	5% (1–16%)	0.60

5-FU=5-fluorouracil.